Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1982 1
1983 1
1985 1
1987 1
1989 1
1996 1
1998 1
1999 2
2000 2
2001 4
2002 5
2003 2
2004 9
2005 9
2006 17
2007 4
2008 19
2009 14
2010 12
2011 21
2012 15
2013 21
2014 19
2015 29
2016 23
2017 24
2018 28
2019 31
2020 13
Text availability
Article attribute
Article type
Publication date

Search Results

306 results
Results by year
Filters applied: . Clear all
Page 1
Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review.
Pittayanon R, Lau JT, Yuan Y, Leontiadis GI, Tse F, Surette M, Moayyedi P. Pittayanon R, et al. Gastroenterology. 2019 Jul;157(1):97-108. doi: 10.1053/j.gastro.2019.03.049. Epub 2019 Mar 30. Gastroenterology. 2019. PMID: 30940523
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is common but difficult to treat. Altering the gut microbiota has been proposed as a strategy for treatment of IBS, but the association between the gut microbiome and IBS symptoms has not been well establi …
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is common but difficult to treat. Altering the gut microbiota has …
Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, Tarpila A, Lahtinen S, Ouwehand AC, Veijola L. Lyra A, et al. World J Gastroenterol. 2016 Dec 28;22(48):10631-10642. doi: 10.3748/wjg.v22.i48.10631. World J Gastroenterol. 2016. PMID: 28082816 Free PMC article. Clinical Trial.
AIM: To determine the effects of Lactobacillus acidophilus NCFM on irritable bowel syndrome (IBS) symptoms and quality of life (QoL). ...
AIM: To determine the effects of Lactobacillus acidophilus NCFM on irritable bowel syndrome (IBS) symptoms and quality …
A Microbial Signature of Psychological Distress in Irritable Bowel Syndrome.
Peter J, Fournier C, Durdevic M, Knoblich L, Keip B, Dejaco C, Trauner M, Moser G. Peter J, et al. Psychosom Med. 2018 Oct;80(8):698-709. doi: 10.1097/PSY.0000000000000630. Psychosom Med. 2018. PMID: 30095672 Free PMC article. Clinical Trial.
OBJECTIVE: Irritable bowel syndrome (IBS) is associated with alterations along the brain-gut-microbiota axis. Previous studies have suggested a parallel segregation of microbial features and psychological burden in IBS. ...
OBJECTIVE: Irritable bowel syndrome (IBS) is associated with alterations along the brain-gut-microbiota axis. Previous …
Efficacy of different probiotic protocols in irritable bowel syndrome: A network meta-analysis.
Liang D, Longgui N, Guoqiang X. Liang D, et al. Medicine (Baltimore). 2019 Jul;98(27):e16068. doi: 10.1097/MD.0000000000016068. Medicine (Baltimore). 2019. PMID: 31277101 Free PMC article.
BACKGROUND: Probiotics is a prevalence therapeutic method for irritable bowel syndrome (IBS), but there is lack of comparison in different protocols. ...
BACKGROUND: Probiotics is a prevalence therapeutic method for irritable bowel syndrome (IBS), but there is lack of comp …
Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
Tap J, Derrien M, Törnblom H, Brazeilles R, Cools-Portier S, Doré J, Störsrud S, Le Nevé B, Öhman L, Simrén M. Tap J, et al. Gastroenterology. 2017 Jan;152(1):111-123.e8. doi: 10.1053/j.gastro.2016.09.049. Epub 2016 Oct 7. Gastroenterology. 2017. PMID: 27725146 Free article.
BACKGROUND & AIMS: We have limited knowledge about the association between the composition of the intestinal microbiota and clinical features of irritable bowel syndrome (IBS). ...
BACKGROUND & AIMS: We have limited knowledge about the association between the composition of the intestinal microbiota and clinical fea …
Gut Microbiome: Profound Implications for Diet and Disease.
Hills RD Jr, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. Hills RD Jr, et al. Nutrients. 2019 Jul 16;11(7):1613. doi: 10.3390/nu11071613. Nutrients. 2019. PMID: 31315227 Free PMC article. Review.
Enterotypes have been proposed using metrics such as alpha species diversity, the ratio of Firmicutes to Bacteroidetes phyla, and the relative abundance of beneficial genera (e.g., Bifidobacterium, Akkermansia) versus facultative anaerobes (E. coli), pro-inflammatory Rumin …
Enterotypes have been proposed using metrics such as alpha species diversity, the ratio of Firmicutes to Bacteroidetes phyla, and the …
The gut microbiome.
Sidhu M, van der Poorten D. Sidhu M, et al. Aust Fam Physician. 2017;46(4):206-211. Aust Fam Physician. 2017. PMID: 28376573 Free article.
OBJECTIVE: This article provides an overview of the gut microbiome in health and disease, highlighting conditions such as Clostridium difficile infection, inflammatory bowel disease, irritable bowel syndrome, obesity and non-alcoholic fatty liver disea …
OBJECTIVE: This article provides an overview of the gut microbiome in health and disease, highlighting conditions such as Clostridium diffic …
Irritable bowel syndrome: a new therapeutic target when treating obesity?
Pugliese G, Muscogiuri G, Barrea L, Laudisio D, Savastano S, Colao A. Pugliese G, et al. Hormones (Athens). 2019 Dec;18(4):395-399. doi: 10.1007/s42000-019-00113-9. Epub 2019 Jun 21. Hormones (Athens). 2019. PMID: 31228102 Review.
Obesity is associated with a change of microbiota composition that not only could increase the calorie extraction from food but also could create a functional derangement resulting in irritable bowel syndrome (IBS). ...The change of levels of some anorexigeni …
Obesity is associated with a change of microbiota composition that not only could increase the calorie extraction from food but also could c …
Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?
Zhou Y, Xu H, Huang H, Li Y, Chen H, He J, Du Y, Chen Y, Zhou Y, Nie Y. Zhou Y, et al. Biomed Res Int. 2019 Jul 29;2019:3469754. doi: 10.1155/2019/3469754. eCollection 2019. Biomed Res Int. 2019. PMID: 31467881 Free PMC article. Review.
Fecal microbiota transplantation (FMT), a type of fecal bacteriotherapy, is considered an effective therapeutic option for recurrent Clostridium difficile infection (rCDI) and also has important value in other intestinal diseases including irritable bowel syndrom
Fecal microbiota transplantation (FMT), a type of fecal bacteriotherapy, is considered an effective therapeutic option for recurrent Clostri …
Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy.
Peter J, Fournier C, Keip B, Rittershaus N, Stephanou-Rieser N, Durdevic M, Dejaco C, Michalski M, Moser G. Peter J, et al. Int J Mol Sci. 2018 Nov 16;19(11):3619. doi: 10.3390/ijms19113619. Int J Mol Sci. 2018. PMID: 30453528 Free PMC article.
Irritable bowel syndrome (IBS) is a disorder with brain-gut-microbiome alterations. Gut-directed hypnotherapy (GHT) has been shown to improve quality of life and symptoms in IBS. ...No significant differences were found in relative bacterial abundances but tr
Irritable bowel syndrome (IBS) is a disorder with brain-gut-microbiome alterations. Gut-directed hypnotherapy (GHT) has
306 results
Jump to page
Feedback